Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-26T00:15:44.311Z.
Calculation as of: 2026-09-26T00:15:44.311Z.
Quote observation: 2026-09-25T20:00:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a867f74022b929e80d197199fbfebc6630f0c88c819bafdecee0647af169585c
PEG RATIO
N/A
Edwards Lifesciences Corporation
Market Cap
$49.69B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Edwards Lifesciences Corporation (EW) | $49.69B | N/A |
| Agilent Technologies, Inc. (A)vs › | $48.80B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $50.65B | N/A |
| Humana Inc. (HUM)vs › | $47.81B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $51.58B | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.64B | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $44.50B | N/A |
| Waters Corporation (WAT)vs › | $42.57B | N/A |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.96B | N/A |
| Cencora, Inc. (COR)vs › | $59.71B | N/A |
PEG Ratio
N/A
P/E Ratio
49.6
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
